Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek to maintain revenue streams and competitive advantages. In this edition of Beyond the Deal, our...more
4/14/2025
/ Acquisitions ,
Artificial Intelligence ,
Biosimilars ,
Biotechnology ,
Competition ,
Generic Drugs ,
Life Sciences ,
Mergers ,
Patent Expiration ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs
The “The Age of AI – Sports and Sports Betting” Webinar offered a brief overview of how generative AI (“GenAI”) works and how AI is being used or is planning to be used in the sports and sports betting industries, and...more